文献速递淋巴瘤

基于西方国家700例患者队列解析Castleman病全谱

Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country.
PubMed 文献 · Br J Haematol · 2026-04-13

该研究利用法国国家Castleman病登记数据库,回顾性分析了700例患者,重新审视了Castleman病三种亚型的全程管理。单中心型通常惰性且可手术治愈,但少数出现严重自身免疫或恶性并发症;HHV8相关多中心型主要见于HIV感染者但也在其他人群中出现;特发性多中心型诊断困难,需与POEMS、TAFRO、IgG4-RD及IPL等重叠综合征鉴别,且西方人群临床表型较亚洲人群更异质。

要点

  • 单中心型Castleman病通常惰性,手术切除可治愈,但需警惕少数严重自身免疫或恶性并发症。
  • HHV8相关多中心型Castleman病不仅见于HIV感染者,也见于其他人群。
  • 特发性多中心型Castleman病诊断挑战大,需与POEMS、TAFRO、IgG4-RD及IPL等鉴别。

核心结论

  • Castleman病应视为包含三种不同疾病的统称,其管理策略因亚型而异。
  • 特发性多中心型Castleman病在西方人群中的临床表型比亚洲人群更异质。

研究设计与样本

  • 基于法国国家Castleman病登记数据库的回顾性队列研究,共纳入700例患者。

主要发现

  • 单中心型Castleman病通常呈惰性病程,可通过手术切除治愈,但小部分患者出现严重自身免疫或恶性并发症。
  • HHV8相关多中心型Castleman病主要见于HIV感染者,但在其他人群中也日益增多。
  • 特发性多中心型Castleman病病理特征与淋巴肿瘤和系统性疾病重叠,诊断具有挑战性。
  • POEMS、TAFRO、IgG4-RD和IPL可与特发性多中心型Castleman病重叠,被视为相关疾病或鉴别诊断。
  • 特发性多中心型Castleman病的临床表型在西方与亚洲人群间存在显著差异,西方人群更异质。

临床怎么用

  • 单中心型Castleman病首选手术切除,同时需监测自身免疫或恶性并发症。
  • HHV8相关多中心型Castleman病应不仅限于HIV感染者,需在更广泛人群中识别。
  • 诊断特发性多中心型Castleman病时需排除POEMS、TAFRO、IgG4-RD及IPL等重叠综合征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Under the Castleman disease (CD) eponym, three distinct diseases sharing common pathological features have been described over time. Using the French national registry for CDs, we revisited the full spectrum of these diseases to update our current knowledge on the optimal management of these patients. The unicentric type (UCD) has usually an indolent course and can be cured by surgical resection. However, a small percentage of the UCD patients develop severe autoimmune or malignant complications. The human herpesvirus 8 (HHV8)-associated multicentric type (HHV8+ MCD) has been mainly described in human immunodeficiency virus (HIV)-infected patients but is an emerging condition outside this setting in other populations. The third type, idiopathic multicentric Castleman disease (iMCD) remains a challenging diagnosis as the pathological features observed in these patients are shared with many other conditions such as lymphoid neoplasia and systemic diseases. Other syndromes such as POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes), TAFRO (thrombocytopenia, anasarca, myelofibrosis, renal dysfunction and organomegaly), IgG4-RD (IgG4-related disease) and IPL (idiopathic plasmacytic lymphadenopathy) may also overlap with iMCD and could be considered either associated conditions or differential diagnosis. In addition, the clinical phenotype of iMCD exhibits several striking differences among populations with a much more heterogeneous pattern in Western populations than in patients of Asian ancestry.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Oksenhendler E, Malphettes M, Meignin V, et al. Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country. Br J Haematol. 2026. PMID: 41968947. doi:10.1111/bjh.70480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。